Effect of the PIPAC on the Survival Rate of Patients With Peritoneal Carcinomatosis of Gastric Origin

NCT04879953 · clinicaltrials.gov ↗

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Carcinomatosis, Peritoneal

Interventions

DRUG: PIPAC with systemic chemotherapy
DRUG: Systemic chemotherapy alone

Sponsor

Association Francaise de Chirurgie